Valeant nears deal to buy Salix for about $10 billion: WSJ
By Reuters
Feb 21, 2015 05:18 PM EST
Regions
The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014. (Photo : Reuters)
Valeant Pharmaceuticals International (VRX.TO) is near a deal to buy Salix Pharmaceuticals Ltd (SLXP.O) for about $10 billion, the Wall Street Journal reported on Saturday.
© Reuters All rights reserved.